aid: brt-biotechnologies

name: BRT Biotechnologies

image: https://framerusercontent.com/assets/4vpajD3S35ibe4wPWghPgtyiS7A.png

description: 'BRT Biotechnologies advances drug discovery by providing high-quality macrocycle libraries that enable rapid identification of promising drug leads. Their platform accelerates the creation of diverse macrocycles, unlocking new possibilities for treating hard‑to‑drug targets and precision therapeutics.'

url: https://raw.githubusercontent.com/api-evangelist/brt-biotechnologies/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-06 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-06'

modified: '2026-10-06'

tags:
- Biotechnology
- Drug Discovery
- Macrocycles
- Therapeutics
- Company

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Plans
  url: plans/brt-biotechnologies-plans-pricing.yml
- type: Hosts
  url: hosts/brt-biotechnologies-hosts.yml
- type: Pricing
  url: https://brtbio.com/archive/pricing
- type: Blog
  url: https://brtbio.com/archive/blog
- type: DomainSecurity
  url: security/brt-biotechnologies-domain-security.yml
- type: Website
  url: https://brtbio.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  method: derived
  generated: '2026-10-06'
  generator: derive-coverage.py (pre-flight evidence)
  detail: >-
    the company publishes no developer documentation host and no machine-readable contract on its own domain
  evidence:
  - url: https://brtbio.com
    status: 200
  - url: https://www.nasdaqprivatemarket.com/
    status: 200
x-enrichment:
  date: '2026-10-06'
  status: enriched
  artifacts_added: 6
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local